Back to trial details

Intake questionnaire

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

Applying to UCSF · San Francisco, California

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you between 9 and 20 years old?
2. Have you been diagnosed with Type 1 Diabetes?
3. Are you able to travel to San Francisco for study visits?